Insiders Buying Adamas One And 1 Other Penny Stock
Insiders Buying Adamas One And 1 Other Penny Stock
The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Adamas One
- The Trade: Adamas One Corp. (NASDAQ:JEWL) President and CEO John Grdina bought a total of 20,000 shares at an average price of $2.51. To acquire these shares, it cost around $50.16 thousand.
- What's Happening: Adamas One recently reported $1.78M in initial lab grown diamond sales for FY22.
- What Adamas One Does: Adamas One Corp is a high-tech diamond company that uses its proprietary technology to produce high-quality, single-crystal diamonds and diamond materials through a CVD process, which it refers to as Diamond Technology.
MAIA Biotechnology
- The Trade: MAIA Biotechnology, Inc. (NYSE:MAIA) Director Stan Smith acquired a total of 236 shares at an average price of $4.24. The insider spent around $1 thousand to buy those shares.
- What's Happening: MAIA Biotechnology expanded its Phase 2 THIO-101 trial to Europe.
- What MAIA Biotechnology Does: MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
Check This Out: Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Gains For Fourth Straight Week
The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
纳斯达克指数连续第四周上涨。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为影响其整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Adamas One
阿达玛斯一号
- The Trade: Adamas One Corp. (NASDAQ:JEWL) President and CEO John Grdina bought a total of 20,000 shares at an average price of $2.51. To acquire these shares, it cost around $50.16 thousand.
- What's Happening: Adamas One recently reported $1.78M in initial lab grown diamond sales for FY22.
- What Adamas One Does: Adamas One Corp is a high-tech diamond company that uses its proprietary technology to produce high-quality, single-crystal diamonds and diamond materials through a CVD process, which it refers to as Diamond Technology.
- 交易： 阿达玛斯一号公司 （纳斯达克股票代码：JEWL）总裁兼首席执行官约翰·格尔迪纳 总共购买了2万股股票 平均价格为2.51美元。收购这些股票的成本约为50.16万美元。
- 发生了什么： Adamas One最近报告称，22财年实验室培育的钻石初始销售额为178万美元。
- Adamas One 做了什么： Adamas One Corp 是一家高科技钻石公司，它利用其专有技术通过 CVD 工艺（它称之为钻石技术）生产高质量的单晶钻石和钻石材料。
MAIA Biotechnology
MAIA 生物技术
- The Trade: MAIA Biotechnology, Inc. (NYSE:MAIA) Director Stan Smith acquired a total of 236 shares at an average price of $4.24. The insider spent around $1 thousand to buy those shares.
- What's Happening: MAIA Biotechnology expanded its Phase 2 THIO-101 trial to Europe.
- What MAIA Biotechnology Does: MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.
- 这笔交易: MAIA 生物技术有限公司 （纽约证券交易所代码：MAIA）导演斯坦·史密斯 共收购了 236 股股份 平均价格为4.24美元。知情人花了大约1万美元购买了这些股票。
- 发生了什么: MAIA Biotechnology 将其第 2 期 THIO-101 试验扩展到欧洲。
- MAIA 生物技术是做什么的: MAIA Biotechnology Inc是一家靶向疗法、免疫肿瘤学公司，专注于开发和商业化具有新作用机制的潜在同类首创药物，旨在有意义地改善和延长癌症患者的寿命。
Check This Out: Fear & Greed Index Remains In 'Greed' Zone As Nasdaq Record Gains For Fourth Straight Week
看看这个： 纳斯达克连续第四周创纪录上涨，恐惧与贪婪指数仍处于 “贪婪” 区域
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧